19 studies found for:    " December 12, 2006":" January 12, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 12, 2006":" January 12, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults
Condition: HIV Infections
Intervention: Biological: HIV LFn-p24
2 Completed Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
Condition: HIV Infections
Interventions: Biological: MRKAd5 HIV-1 gag/pol/nef;   Other: Placebo
3 Withdrawn Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA016-00-VP;   Biological: VRC-HIVADV014-00-VP;   Biological: Vaccine placebo
4 Completed Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: ritonavir
5 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
6 Unknown  A Long-term Follow-up of the HIV-NAT Cohort
Condition: HIV Infections
Intervention:
7 Terminated Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
Condition: HIV Infection
Interventions: Drug: atazanavir;   Drug: lopinavir/ritonavir
8 Completed A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Prednisone;   Drug: placebo
9 Completed
Has Results
Metabolic Effects of Switching Kaletra to Boosted Reyataz
Condition: HIV Infections
Interventions: Drug: atazanavir/ritonavir;   Drug: lopinavir/ritonavir
10 Active, not recruiting
Has Results
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
Condition: HIV Infections
Interventions: Drug: Tenofovir DF;   Drug: Zidovudine;   Drug: Stavudine
11 Completed Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
Conditions: HIV Infections;   Malaria
Intervention: Drug: Atovaquone / Proguanil
12 Completed Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only
Condition: HIV Infections
Intervention: Drug: Nevirapine
13 Completed
Has Results
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: tenofovir;   Drug: emtricitabine
14 Terminated BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
Condition: HIV Infections
Intervention: Drug: Increased dose of Kaletra
15 Completed The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: indinavir/ritonavir
16 Completed
Has Results
Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate/Emtricitabine;   Drug: Lopinavir/Ritonavir
17 Completed Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Drug: Atazanavir
18 Completed TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients
Conditions: Anti-Retroviral Agents;   HIV-1
Intervention: Drug: TMC125
19 Completed A Trial of Zinc and Micronutrients in Tanzanian Children
Conditions: Diarrheal Illnesses;   Respiratory Illness;   Growth Faltering
Interventions: Drug: Zinc;   Drug: Multivitamins;   Drug: Placebo

Indicates status has not been verified in more than two years